EPS Diluted (Annual) Chart

View EPS Diluted (Annual) for ALKS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Annual) Chart
Start Trial

Historical EPS Diluted (Annual) Data

View and export this data back to 1980. Start Trial.
Date Value
December 31, 2025 1.432
December 31, 2024 2.170
December 31, 2023 2.096
December 31, 2022 -0.9666
December 31, 2021 -0.2993
December 31, 2020 -0.6981
December 31, 2019 -1.252
December 31, 2018 -0.8981
December 31, 2017 -1.03
December 31, 2016 -1.38
December 31, 2015 -1.52
December 31, 2014 -0.21
December 31, 2013 0.1616
March 31, 2012 -0.99
March 31, 2011 -0.48
March 31, 2010 -0.42
March 31, 2009 1.36
March 31, 2008 1.62
Date Value
March 31, 2007 0.09
March 31, 2006 0.04
March 31, 2005 -0.82
March 31, 2004 -1.25
March 31, 2003 -1.66
March 31, 2002 -0.96
March 31, 2001 -0.43
March 31, 2000 -0.76
March 31, 1999 -0.99
March 31, 1998 -0.235
March 31, 1997 -0.515
March 31, 1996 -0.465
March 31, 1995 -0.44
March 31, 1994 -0.645
March 31, 1993 -1.885
March 31, 1992 -0.49
March 31, 1991 0.00
March 31, 1980 0.00

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Annual) Range, Past 5 Years

View EPS Diluted (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Annual) Benchmarks

View EPS Diluted (Annual) Benchmarks
Start Trial
Amarin Corp. Plc -1.874
Jazz Pharmaceuticals Plc -5.840
Prothena Corp. Plc -4.535
ACADIA Pharmaceuticals, Inc. 2.301
Biogen, Inc. 8.789